Ten healthy volunteers were given 250 mg cefuroxime-axetil tablets b.i
.d. for 10 d. Stool samples were collected before, during and after ce
furoxime-axetil administration. The mean concentrations of cefuroxime
in faeces on days 7 and 10 were 0.57 mg/kg (range <0.125-0.84 mg/kg) a
nd 0.48 mg/kg (range <0.125-1.35 mg/kg) respectively. There was an ove
rgrowth of enterococci and staphylococci, while the levels of bacilli
and enterobacteria were not significantly altered during the administr
ation period. Six subjects became colonised by Candida albicans and th
ree by Clostridium difficile during and after the administration perio
d. Two of the volunteers with C. difficle reported mild diarrhoea duri
ng the administration period. The number of bifidobacteria and clostri
dia decreased while the levels of eubacteria and bacteroides were unaf
fected by cefuroxime-axetil administration. Beta-Lactamase activities
in faeces were found in six volunteers and increased significantly dur
ing the administration period (P<0.05). There was a clear relationship
between beta-lactamase activities in faeces, concentrations of cefuro
xime and alterations in the normal microflora. Low cefuroxime concentr
ations in faeces corresponded to high beta-lactamase activities and mi
nor alterations in the normal microflora, while high cefuroxime concen
trations in faeces corresponded to low beta-lactamase activities and c
onsiderable ecological disturbances in the faecal microflora.